morpholine has been researched along with salicylates in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| SAMMARTINO, V | 1 |
| Ali, A; Duong, HQ; Khan, IU; Li, ZT; Lin, YJ; Rahman, FU; Wang, H; Yu, SB; Zhang, DW | 1 |
2 other study(ies) available for morpholine and salicylates
| Article | Year |
|---|---|
Clinical experiences with morpholine salicylate
Topics: Analgesics; Heterocyclic Compounds; Morpholines; Salicylates | 1962 |
Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Escherichia coli; Humans; Microbial Sensitivity Tests; Molecular Structure; Morpholines; Organoplatinum Compounds; Piperazines; Platinum; Salicylates; Structure-Activity Relationship | 2017 |